These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Tumour lysis syndrome after treatment of chronic lymphocytic leukaemia with fludarabine.
    Author: Montalban C, Liaño F, Aguilera A.
    Journal: Postgrad Med J; 1994 Sep; 70(827):651-2. PubMed ID: 7971632.
    Abstract:
    Fludarabine is one of the most recent and promising therapeutic agents for chronic lymphocytic leukaemia. We describe a patient who developed tumour lysis syndrome after the first course of treatment with fludarabine and call attention to this uncommon but potentially lethal complication that has not been previously taken into account in this neoplasia. It should always be anticipated when patients are treated with new and effective drugs.
    [Abstract] [Full Text] [Related] [New Search]